Giulio Porcedda Selected Research

Digoxin (Digitek)

1/2021

Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giulio Porcedda Research Topics

Disease

2	Tachycardia (Tachyarrhythmias) 01/2021 - 11/2020
1	Aortic Coarctation 04/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2023
1	Progeria (Hutchinson Gilford Syndrome) 03/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2023
1	Atherosclerosis 03/2023
1	Acute Coronary Syndrome 03/2023
1	Granuloma 01/2020
1	Left Ventricular Dysfunction 10/2017
1	Heart Diseases (Heart Disease) 10/2017
1	Hemangioma (Angioma) 04/2017

Drug/Important Bio-Agent (IBA)

2	Flecainide (Tambocor)FDA LinkGeneric 01/2021 - 11/2020
2	Nadolol (Corgard)FDA LinkGeneric 01/2021 - 11/2020
1	Coenzyme A (CoA)IBA 04/2023
1	Lamin Type A (Lamin A)IBA 03/2023
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2021
1	Digoxin (Digitek)FDA LinkGeneric 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2021
1	Polyvinyl Chloride (PVC)IBA 10/2017
1	Propranolol (Inderal)FDA LinkGeneric 04/2017

Therapy/Procedure

1	Percutaneous Coronary Intervention 03/2023
1	Therapeutics 01/2021
1	Stents 01/2020